Provided by Tiger Fintech (Singapore) Pte. Ltd.

Akoya Biosciences, Inc.

1.10
+0.01501.38%
Volume:174.19K
Turnover:189.39K
Market Cap:54.80M
PE:-0.98
High:1.13
Open:1.05
Low:1.02
Close:1.09
Loading ...

Akoya Biosciences (AKYA) Reports Q4 Loss, Lags Revenue Estimates

Zacks
·
18 Mar

Akoya Biosciences Q4 2024 GAAP EPS $(0.17) Misses $(0.16) Estimate, Sales $21.344M Beat $21.338M Estimate

Benzinga
·
18 Mar

Akoya Biosciences Inc Q4 Shr View $-0.16, REV View $21.3 Mln -- Lseg Ibes Data

THOMSON REUTERS
·
18 Mar

Akoya Biosciences Inc Qtrly Revenue Was $21.3 Million

THOMSON REUTERS
·
18 Mar

Press Release: Akoya Reports Fourth Quarter of 2024 and Full Year Financial Results

Dow Jones
·
18 Mar

Press Release: Kent Lake Urges Quanterix Management to Address Key Questions Regarding its Proposed Transaction with Akoya Biosciences During Today's Earnings Call

Dow Jones
·
18 Mar

Sector Update: Health Care Stocks Slide in Afternoon Trading

MT Newswires Live
·
12 Mar

Quanterix Shareholder Opposes Proposed Akoya Biosciences Merger

MT Newswires Live
·
11 Mar

Kent Lake Issues Investor Presentation Detailing Opposition to Quanterix’s Proposed Merger with Akoya Biosciences

Business Wire
·
11 Mar

Piper Sandler Downgrades Akoya Biosciences to Neutral From Overweight, Adjusts Price Target to $2.40 From $3

MT Newswires Live
·
05 Mar

Hold Rating on Quanterix-Akoya Merger Amid Uncertainties and Potential Synergies

TIPRANKS
·
05 Mar

Akoya Biosciences downgraded to Neutral from Overweight at Piper Sandler

TIPRANKS
·
05 Mar

U.S. RESEARCH ROUNDUP-Accolade, CrowdStrike, Marriott International

Reuters
·
05 Mar

Akoya Biosciences Inc : Piper Sandler Cuts to Neutral From Overweight; Cuts Target Price to $2.4 From $3

THOMSON REUTERS
·
05 Mar

Quanterix Announces Acquisition of Akoya Biosciences

TIPRANKS
·
04 Mar

Kent Lake Nominates Three Highly Qualified, Independent Candidates for Quanterix Board

Business Wire
·
03 Mar

Quanterix Highlights Compelling Benefits of Akoya Biosciences Acquisition

Business Wire
·
03 Mar

Akoya Biosciences Inc expected to post a loss of 16 cents a share - Earnings Preview

Reuters
·
28 Feb

Kent Lake: to Nominate Directors to Quanterix Board in 2025 Annual Meeting

THOMSON REUTERS
·
19 Feb

Kent Lake Pr Llc: Believes Merger Agreement With Akoya Biosciences Significantly Undervalues Quanterix

THOMSON REUTERS
·
19 Feb